The United States decides to dispose of millions of doses of the Johnson & Johnson vaccine

After a weeks-long review of a factory in Baltimore, Maryland, that suffers from production problems, the US federal health authorities decided to dispose of about 60 million doses of the “Johnson & Johnson” coronavirus vaccine produced at the factory, due to possible contamination, according to the New York newspaper. Times" for "people familiar with the case."

The newspaper said the Food and Drug Administration intends to allow about 10 million doses to be distributed in the United States or sent to other countries, but with a warning that the relevant authorities cannot guarantee that "Emergent BioSolutions", the company that runs the plant, followed good manufacturing procedures.

The newspaper added, quoting sources, that the Food and Drug Administration has not yet decided whether the company can reopen the factory, which has been closed for two months due to regulatory concerns.

The Food and Dizziness Agency has been trying for weeks to figure out what to do with about 170 million doses of the vaccine that were kept after discovering a major problem with two vaccines manufactured at the site.

Authorities have seized more than 100 million doses of Johnson & Johnson and at least 70 million doses of AstraZeneca after Emergent discovered in March that its workers had contaminated a batch of Johnson & Johnson's vaccine with a key ingredient used. For the production of "AstraZeneca".

According to the newspaper, federal officials then ordered the plant to temporarily halt production, strip Emergent of its responsibility to produce the “AstraZeneca” vaccine, and instruct Johnson & Johnson to assert direct control over its vaccine manufacturing there.

Last April, the United States decided to suspend the distribution of the "Johnson & Johnson" vaccine until investigations were completed regarding the sixth rare case of blood clotting, linked to a low platelet count.

Reports said that the blood clots associated with the vaccine are very similar to the cases caused by the "AstraZeneca" vaccine in Europe.

The US Food and Drug Administration and the Centers for Disease Control and Prevention authorized the resumption of work on the "Johnson & Johnson" vaccine, after an 11-day suspension.

The Johnson & Johnson vaccine was welcomed at its launch because it can be taken in only one dose and stored at normal temperatures in refrigerators.

Follow our latest local and sports news and the latest political and economic developments via Google news